MolDX proposes Medicare coverage for genome-wide hematologic testing

Go back to MolDX proposes Medicare coverage for genome-wide hematologic testing
(NASDAQ: BNGO) Delayed: 1.13 -0.05 (4.24%)
Previous Close $1.18    52 Week High $ 
Open $1.18    52 Week Low $ 
Day High $1.18    P/E N/A 
Day Low $1.10    EPS $ 
Volume 251,889